Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech a high priority of E700 million EU nanotech drive

This article was originally published in Clinica

Executive Summary

Machines no bigger than a molecule will one day surf our blood stream, search and destroy infected tissues and heal our wounds." This is how the European Commission prefaced a pledge to spend E700m ($625m) on nanotechnology research over the next four years, under the forthcoming sixth research framework programme (FP6), in which medical technology promises to take centre stage.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066905

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel